Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 373

1.

Inflammatory Muscle Diseases.

Dalakas MC.

N Engl J Med. 2015 Jul 23;373(4):393-4. doi: 10.1056/NEJMc1506827. No abstract available.

2.

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis.

Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 2;2(4):e131. doi: 10.1212/NXI.0000000000000131. eCollection 2015 Aug. No abstract available.

3.

Treatment for inclusion body myositis.

Rose MR, Jones K, Leong K, Walter MC, Miller J, Dalakas MC, Brassington R, Griggs R.

Cochrane Database Syst Rev. 2015 Jun 30;6:CD001555. doi: 10.1002/14651858.CD001555.pub5.

PMID:
26125437
4.

HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.

Muth IE, Zschüntzsch J, Kleinschnitz K, Wrede A, Gerhardt E, Balcarek P, Schreiber-Katz O, Zierz S, Dalakas MC, Voll RE, Schmidt J.

Exp Neurol. 2015 Jun 3;271:189-197. doi: 10.1016/j.expneurol.2015.05.023. [Epub ahead of print]

PMID:
26048613
5.

Inflammatory muscle diseases.

Dalakas MC.

N Engl J Med. 2015 Apr 30;372(18):1734-47. doi: 10.1056/NEJMra1402225. Review. No abstract available.

PMID:
25923553
6.

GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders.

Fouka P, Alexopoulos H, Akrivou S, Trohatou O, Politis PK, Dalakas MC.

J Neuroimmunol. 2015 Apr 15;281:73-7. doi: 10.1016/j.jneuroim.2015.03.009. Epub 2015 Mar 10.

PMID:
25867471
7.

Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.

Chin RL, Deng C, Bril V, Hartung HP, Merkies IS, Donofrio PD, Van Doorn PA, Dalakas MC, Latov N.

Muscle Nerve. 2015 Feb 27. doi: 10.1002/mus.24624. [Epub ahead of print]

PMID:
25728021
8.

Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.

Stathopoulos P, Alexopoulos H, Dalakas MC.

Nat Rev Neurol. 2015 Mar;11(3):143-56. doi: 10.1038/nrneurol.2014.260. Epub 2015 Jan 27. Review.

PMID:
25623793
9.

Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.

Lünemann JD, Nimmerjahn F, Dalakas MC.

Nat Rev Neurol. 2015 Feb;11(2):80-9. doi: 10.1038/nrneurol.2014.253. Epub 2015 Jan 6. Review.

PMID:
25561275
10.

7th International Immunoglobulin Conference: Interlaken Leadership Awards.

Dalakas MC, Löscher WN.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:138. doi: 10.1111/cei.12544.

PMID:
25546795
11.

7th International Immunoglobulin Conference: Interlaken Leadership Awards.

Dalakas MC, Löscher WN.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:124-6. doi: 10.1111/cei.12538.

PMID:
25546789
12.

Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expression.

Alexopoulos H, Dagklis IE, Akrivou S, Bostantjopoulou S, Dalakas MC.

Neurol Neuroimmunol Neuroinflamm. 2014 Oct 29;1(4):e39. doi: 10.1212/NXI.0000000000000039. eCollection 2014 Dec. No abstract available.

13.

Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study.

Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, Moutsopoulos HM, Tzioufas AG, Dalakas MC.

J Neurol Sci. 2014 Dec 15;347(1-2):143-7. doi: 10.1016/j.jns.2014.09.035. Epub 2014 Sep 28.

PMID:
25304055
14.

Reliability of the adult myopathy assessment tool in individuals with myositis.

Harris-Love MO, Joe G, Davenport TE, Koziol D, Abbett Rose K, Shrader JA, Vasconcelos OM, McElroy B, Dalakas MC.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):563-70. doi: 10.1002/acr.22473.

PMID:
25201624
15.

Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase.

Markakis I, Alexopoulos H, Poulopoulou C, Akrivou S, Papathanasiou A, Katsiva V, Lyrakos G, Gekas G, Dalakas MC.

J Neurol Sci. 2014 Aug 15;343(1-2):192-4. doi: 10.1016/j.jns.2014.05.032. Epub 2014 May 27.

PMID:
24950904
16.

Pathogenesis of immune-mediated neuropathies.

Dalakas MC.

Biochim Biophys Acta. 2015 Apr;1852(4):658-666. doi: 10.1016/j.bbadis.2014.06.013. Epub 2014 Jun 17. Review.

PMID:
24949885
17.

Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations.

Dalakas MC.

J Clin Immunol. 2014 Jul;34 Suppl 1:S120-6. doi: 10.1007/s10875-014-0024-5. Epub 2014 Apr 11. Review.

PMID:
24722854
18.

IVIg in the chronic management of myasthenia gravis: is it enough for your money?

Dalakas MC.

J Neurol Sci. 2014 Mar 15;338(1-2):1-2. doi: 10.1016/j.jns.2013.12.034. Epub 2013 Dec 27. No abstract available.

PMID:
24411405
19.

Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders.

Alexopoulos H, Akrivou S, Dalakas MC.

Neurology. 2013 Nov 26;81(22):1962-4. doi: 10.1212/01.wnl.0000436617.40779.65. Epub 2013 Oct 30. No abstract available.

PMID:
24174585
20.

Immunology of stiff person syndrome and other GAD-associated neurological disorders.

Alexopoulos H, Dalakas MC.

Expert Rev Clin Immunol. 2013 Nov;9(11):1043-53. doi: 10.1586/1744666X.2013.845527. Review.

PMID:
24168411
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk